This process results in the release of damage‐associated molecular patterns (DAMPs), further promoting the infiltration of CD8+ T cells within the tumor, thereby enhancing the anti‐tumor efficacy of immunotherapy [53]. The gene discussed is CD8A; the disease is neoplasm.